|

LP-284 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • Lantern Pharma Inc.1

Indications

  • Relapsed or Refractory Lymphomas1
  • Advanced Solid Tumor1
  • Cancer1

Los Alamitos, California1 trial

Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors

Cancer and Blood Specialists Clinic

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.